Pontocerebellar Hypoplasia Type 9: A New Case with a Novel Mutation and Review of Literature

Abstract

Pontocerebellar hypoplasia type 9 (PCH-9) is a very rare autosomal recessive neurodegenerative disorder. Affected infants present early with severe developmental delay, spasticity, with the unique magnetic resonance imaging picture of thin corpus callosum, atrophied pons, and cerebellum. It is caused by loss of function mutations in the AMPD2 gene, encoding for the adenosine monophosphate deaminase enzyme-paralog 2. This gene is expressed in different somatic tissues with high level of expression in cerebellum and its encoded enzyme catalyzes a critical step in de novo biosynthesis of purines and its deficiency in the developing neurons severely affects neuronal differentiation and cell viability. We clinically evaluated an Emirati patient presented with severe developmental and growth delay, as well as corpus callosum agenesis and atrophy of brainstem and cerebellum. We performed exome sequencing, Sanger sequencing, and segregation analysis to identify the genetic cause of the phenotype, followed by in silico and in vitro analysis. We identified the novel variant (NM_004037.9:c.1471G > A) in AMPD2 gene leading to a single amino acid substitution (p.Gly491Arg) in adenosine monophosphate deaminase-2 enzyme. This variant is predicted to be pathogenic using several in silico tools, and resulted in a decrease in the enzyme function in the patient's polymorphonuclear cells by 82% (95% confidence interval: 73.3–91.7%, p = 0.029) compared with the control. This data establishes that the affected child is affected by PCH-9. Furthermore, we review all reported cases in literature to summarize the main clinical features of this rare disease.

Keywords

pontocerebellar hypoplasia - corpus callosum agenesis - adenosine monophosphate deaminase 2

^$ Co-Senior authors

Publication History

Received: 31 May 2021

Accepted: 07 March 2022

Article published online:
20 May 2022

• References

• 1 Namavar Y, Barth PG, Poll-The BT, Baas F. Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia. Orphanet J Rare Dis 2011; 6: 50 DOI: 10.1186/1750-1172-6-50.
• 2 Akizu N, Cantagrel V, Schroth J. et al. AMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder. Cell 2013; 154 (03) 505-517
• 3 GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013; 45 (06) 580-585
• 4 Wilhelm M, Schlegl J, Hahne H. et al. Mass-spectrometry-based draft of the human proteome. Nature 2014; 509 (7502): 582-587
• 5 Wasmuth EV, Lima CD. The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res 2017; 45 (D1): D158-D169
• 6 Yüksel B, Özbek MN, Mungan NÖ. et al. Children between 0 and 6 years of age. 2011; 3 (02) 84-88
• 7 Lek M, Karczewski KJ, Minikel EV. et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536 (7616): 285-291
• 8 Meyer SL, Kvalnes-Krick KL, Schramm VL. Characterization of AMD, the AMP deaminase gene in yeast. Production of AMD strain, cloning, nucleotide sequence, and properties of the protein. Biochemistry 1989; 28 (22) 8734-8743
• 9 Van Den Berghe G, Vincent MF, Marie S. Disorders of purine and pyrimidine metabolism. Inborn Metabolic Diseases: Diagnosis Treatment 2012; 86: 499-518
• 10 Novarino G, Fenstermaker AG, Zaki MS. et al. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science 2014; 343 (6170): 506-511
• 11 Farwell KD, Shahmirzadi L, El-Khechen D. et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genet Med 2015; 17 (07) 578-586
• 12 Marsh AP, Lukic V, Pope K. et al. Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss. Neurol Genet 2015; 1 (02) e16
• 13 Marsh APL, Yap P, Tan T. et al. A novel AMPD2 mutation outside the AMP deaminase domain causes pontocerebellar hypoplasia type 9. Am J Med Genet A 2017; 173 (03) 820-823
• 14 Accogli A, Iacomino M, Pinto F. et al. Novel AMPD2 mutation in pontocerebellar hypoplasia, dysmorphisms, and teeth abnormalities. Neurol Genet 2017; 3 (05) e179
• 15 Hengel H, Buchert R, Sturm M. et al. First-line exome sequencing in Palestinian and Israeli Arabs with neurological disorders is efficient and facilitates disease gene discovery. Eur J Hum Genet 2020; 28 (08) 1034-1043
• 16 Kortüm F, Jamra RA, Alawi M. et al. Clinical and genetic spectrum of AMPD2-related pontocerebellar hypoplasia type 9. Eur J Hum Genet 2018; 26 (05) 695-708
• 17 Karaca E, Posey JE, Coban Akdemir Z. et al. Phenotypic expansion illuminates multilocus pathogenic variation. Genet Med 2018; 20 (12) 1528-1537